Brief: CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
19/08/2024 13:42
Aug 19 (Reuters) - Collplant Biotechnologies Ltd
CPTG.F :
* COLLPLANT AND STRATASYS ANNOUNCE PRE-CLINICAL STUDY FOR
REGENERATIVE COMMERCIAL-SIZED BREAST IMPLANTS
Source text for Eikon: ID:nBw3m22Pha
Further company coverage: CPTG.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stratasys
See all newsBrief: Stratasys And Limbitless Solutions Expand Ongoing Partnership Providing Access To 3D-Printed Prosthetics For Children
Stratasys Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's Stratasys Q2 profit beats on aerospace, defense segment growth
Brief: Stratasys - Awarded $7.80 Million Funding Through 2026 America Makes And Department Of War Challenge
Stratasys Ltd expected to post earnings of 1 cent a share - Earnings Preview